PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$73.03 USD
-0.89 (-1.20%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $73.01 -0.02 (-0.03%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
Prestige Consumer Healthcare (PBH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$83.33 | $95.00 | $75.00 | 12.73% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Prestige Consumer Healthcare comes to $83.33. The forecasts range from a low of $75.00 to a high of $95.00. The average price target represents an increase of 12.73% from the last closing price of $73.92.
Analyst Price Targets (3 )
Broker Rating
Prestige Consumer Healthcare currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/24/2024 | D.A. Davidson | Linda B Weiser | Hold | Strong Buy |
5/16/2024 | William Blair | Jon R Andersen | Strong Buy | Strong Buy |
4/2/2024 | Canaccord Genuity | Susan K Anderson | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $83.33 |
LT Growth Rate | 8.00% |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 1.08 |
PBH FAQs
Prestige Consumer Healthcare Inc. (PBH) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Prestige Consumer Healthcare Inc. (PBH) is $83.33. The current on short-term price targets is based on 4 reports.
The forecasts for Prestige Consumer Healthcare Inc. (PBH) range from a low of $75 to a high of $95. The average price target represents a increase of $14.10 from the last closing price of $73.03.
The current UPSIDE for Prestige Consumer Healthcare Inc. (PBH) is 14.10%
Based on short-term price targets offered by three analysts, the average price target for Prestige Consumer Healthcare comes to $83.33. The forecasts range from a low of $75.00 to a high of $95.00. The average price target represents an increase of 12.73% from the last closing price of $73.92.